Lv1
80 积分 2025-09-03 加入
Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4 + CD25 + T cell ratio in early stage NK/T cell lymphoma patients may predict worse outcome
16天前
已完结
Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification
18天前
已完结
DDGP-based chemoradiotherapy versus radiotherapy alone in newly diagnosed early-stage extranodal NK/T-cell lymphoma: A single-center retrospective analysis
20天前
已完结
Mechanisms and interventions in relapsed/refractory extranodal natural killer/T-cell lymphoma
20天前
已完结
A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma
3个月前
已完结
An evaluation of sugemalimab for the treatment of relapsed or refractory extranodal natural killer T-cell lymphoma
7个月前
已完结
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase
7个月前
已完结
From infection to immune exhaustion: The Epstein-Barr virus and its contribution to Immunosenescence
8个月前
已完结
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
8个月前
已完结
Encouraging prospects with sugemalimab in relapsed or refractory extranodal natural killer/T-cell lymphoma
9个月前
已完结
皖公网安备34019202002308
